| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2164312 | Update on Cancer Therapeutics | 2006 | 13 Pages |
Abstract
This article reviews the mechanism of action, toxicity, pharmacology and clinical use of antineoplastic agents that inhibit the enzyme, topoisomerase II. Information presented in the medical and scientific literature in the past 3 years is especially highlighted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kenneth R. Hande,